Aurobindo Pharma Mulls Spinning Off Units

Drug maker Aurobindo Pharma is evaluating restructuring options including spinning off its active pharmaceutical ingredient and formulations unit in a bid to unlock value of an expanding segment of its business. The Hyderabad-based company made this announcement, and followed it with its results, which showed a net profit increase of 13% to 5.94 billion rupees ($132.94 million) for the year ended March 31 compared with 5.26 billion rupees ($117.72 million) in the previous year.